David Lang

12PUBLICATIONS
13CO-AUTHORS
Epidemiological modellingRadiology and organ imagingImmunogenetics (incl. genetic immunology)Predictive and prognostic markersMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 19, 2026
Statin use and its implications on survival and disease progression in the European MultiPartner idiopathic pulmonary fibrosis registry (EMPIRE).

David Lang, Bernd Lamprecht, Nesrin Mogulkoc

|Jan 07, 2026
Prognostic Implications of Volume-based Quantitative 18F-FDG PET/CT Biomarkers in Pulmonary Sarcoidosis.

Guangyu Shao, Bernhard Kaiser, Michael Gabriel

|Jul 27, 2024
Functional Improvement at One Year in Fibrotic Interstitial Lung Diseases-Prognostic Value of Baseline Biomarkers and Anti-Inflammatory Therapies.

Guangyu Shao, Paul Thöne, Bernhard Kaiser

|Jul 27, 2024
Real-World Treatment Patterns and Timeliness of Clinical Care Pathway for Non-Small Cell Lung Cancer Patients in Austria: The PRATER Retrospective Study.

Maximilian Hochmair, Angelika Terbuch, David Lang

|Jun 18, 2024
Smoking-Associated Endotracheal Hair Growth: A Case Report on Tracheal Complications.

Paul Thöne, Roland Kropfmüller, Daniela Gompelmann

|Jan 11, 2022
Sex-Based Clinical Outcome in Advanced NSCLC Patients Undergoing PD-1/PD-L1 Inhibitor Therapy-A Retrospective Bi-Centric Cohort Study.

David Lang, Anna Brauner, Florian Huemer

Pageof 2

Frequent Collaborators

3 joint publications

Bernd Lamprecht

1 joint publications

Kaveh Akbari

1 joint publications

Florian Huemer

1 joint publications

Gabriel Rinnerthaler